baber/WOPTO huggingface dataset:
Patent NZ-528096-A (NZ)
Title: Structural frameworks of webs and therefor
Inventor: COLL STEPHEN ANTHONY
IPC: E04C3/11
Filed: 2003-09-08
Abstract: An elongate metal member for use as a brace between timber components, wherein the member is a tab ended substantially straight bodied elongate member with an elongate axis extending along its length between the tabs, and wherein each tab has at least one opening to receive, for tab fastening purposes to a timber component, a fastener to be penetrative of a said timber component, the cross-section of each tab being substantially planar when compared to the cross-section of the substantially straight elongate body which accounts for the majority of the length of the elongate metal member, and wherein each tab has substantially a general plane aligned with, angled to a side or angled to opposite sides of the elongate axis of the substantially straight elongate body, and wherein prior to and/or during tab fixing by said fasteners, at least substantially to the extent required by the timber component spacing and the length of the elongate body, to enable the tabs to lie with their general plane substantially parallel to the elongate axis of each said timber component, each general plane of a said tab can be articulated relative to the elongate axis of the substantially straight elongate body. (62) Divided out of 518135
Patent NZ-529509-A (NZ)
Title: Production of oil seed protein isolate
Inventor: BARKER LARRY D
IPC: A23L1/305
Filed: 2002-05-03
Abstract: Oil seed protein isolates, particularly canola protein isolate, are produced at a high purity level of at least about 100 wt% (N x 6.25) by a process wherein oil seed protein is extracted from oil seed meal, the resulting aqueous protein solution is concentrated to a protein content of at least about 200 g/L, and the concentrated protein solution is added to chilled water having a temperature below about 15 DEG C to form protein micelles, which are settled to provide a protein micellar mass (PMM). The protein micellar mass is separated from supernatant and may be dried. The supernatant may be processed to recover additional oil seed protein isolate by concentrating the supernatant and then drying the concentrated supernatant, to produce a protein isolate having a protein content of at least about 90 wt%. The concentrated supernatant may be mixed in varying proportions with at least part of the PMM and the mixture dried to produce a protein isolate having a protein content of at least about 90 wt%.
Patent NZ-529940-A (NZ)
Title: Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
Inventor: DULHUNTY ANGELA FAY
IPC: A61P31/04
Filed: 2002-05-17
Abstract: A pharmaceutical composition comprises a fragment of a skeletal dihydropyridine receptor polypeptide that comprises a RKRRK motif or a functional derivative, homologue or analogue thereof for modulating the activity of a cardiac ryanodine receptor calcium channel and can be used for treating cardiac dysfunction. Also described are methods for the identification of a peptide or non-peptide modulator of a cardiac ryanodine receptor calcium channel.
Patent NZ-530826-A (NZ)
Title: Water-insoluble drugs co-ground with a cross-linked polymeric carrier in dry conditions so they are more soluble and bioavailable
Inventor: BRESCIANI MASSIMO
IPC: A61K9/48
Filed: 2002-06-03
Abstract: Described is a process for preparing a highly activated composite of one or more water-insoluble drugs, the process comprising the steps of: (a) subjecting a water-insoluble drug and a cross-linked polymer to co-grinding; (b) exposing the ground product of step (a) to contact with water or water vapours. The resulting composite contains large amounts of drug in the easily soluble amorphous form, reduced amounts of drug in the nanocrystalline form, and is substantially free from insoluble drug crystals.
Patent NZ-531726-A (NZ)
Title: Load transfer plate for in situ concrete slabs
Inventor: BOXALL RUSSELL
IPC: E01C11/14
Filed: 2002-09-13
Abstract: A tapered load plate transfers loads across a joint between adjacent concrete floor slabs. The top and bottom surfaces may taper from approximately 4 inches wide to a narrow substantially pointed end over a length of approximately 12 inches. The tapered load plate accommodates differential shrinkage of cast-in-place concrete slabs. When adjacent slabs move away from each other, the narrow end of the tapered load plate moves out of the void that it created in the slab thus allowing the slabs to move relative to one another in a direction parallel to the joint. Tapered load plates may be assembled into a load-plate basket with the direction of the taper alternating from one tapered load plate to the next to account for off-center saw cuts. A tapered load plate and an end cap may be used to provide load transfer across an expansion joint.
Patent NZ-533430-A (NZ)
Title: Tetrahydrocarbozole derivatives as ligands for G-protein coupled receptors (GPCR)
Inventor: KOPPITZ MARCUS
IPC: C07D401/12
Filed: 2002-12-16
Abstract: A compound of the general formula (I) is described. The radical R1 is a hydrogen atom, a C2-C6 alkenyl or a C1-C6 alkyl radical and may optionally be substituted. The radicals R2, R3, R4 and R5 are each independently of one another a hydrogen atom, a halogen atom, the group -COOH, -CONH2, -CF3, -OCF3, -NO2, -CN, a C1-C6 alkyl, a C2-C6 alkenyl, a C1-C6 alkoxy, a C1-C12 aralkyl, an aryl or hetaryl radical. The radical R6 is the group -CONR8R9, -COOR8, -CH2NR8R9, -CH2R8, -CH2OR8, or a C2-C12 alkenyl radical which is optionally substituted by the radicals R8 and R9. The radical R7 is a C1-C12 alkyl, a C2-C12 alkenyl, a C1-C12 aralkyl, an aryl or hetaryl radical, the group -NR12R13, -NHCOR14, -NHCONHR14, -NHCOOR14 or -NHSO2R14 and may be optionally substituted. The radicals Ra, Rb, Rc, Rd, Re and Rf are each independently of one another a hydrogen atom, a halogen atom, the group -COOH, -CONH2, -CF3, -OCF3, -NO2, -CN, a C1-C6 alkyl, C1-C6 alkoxy, an aryl or hetaryl radical. A proviso explains that the compound of the general formula (I) is not selected from the group consisting of 3-amino-1,2,3,4-tetrahydrocarbazole-3-carboxylic acid, 3-amino-6-methoxy-1,2,3,4-tetrahydrocarbazole-3-carboxylic acid, 3-amino-6-benzyloxy-1,2,3,4-tetrahydrocarbazole-3-carboxylic acid, 3-acetamido-1,2,3,4-tetrahydrocarbazole-3- carboxylic acid, methyl 3-acetamido-1,2,3,4-tetrahydrocarbazole-3-carboxylate, (-) -menthyl 3- acetamido-1,2,3,4-tetrahydrocarbazole-3-carboxylate or 3-tert-butoxycarbonylamino-1,2,3, 4-tetrahydrocarbazole-3-carboxylic acid. The compound is disclosed to be used in a pharmaceutical for the treatment of pathological states mediated by G protein-coupled receptors, such as for male fertility control, treatment of female subfertility or infertility, and female contraception.
Patent NZ-534134-A (NZ)
Title: Glass lamination with low-water content plastic interlayer, formed by pressing, and subsequent heating at atmospheric or higher pressure
Inventor: BOURCIER DAVID PAUL
IPC: B32B17/10
Filed: 2002-12-23
Abstract: Glass laminates are prepared using low-water content plastic interlayer material, such as polyvinylbutyral interlayer sheets, by a process employing nip roll de-airing, and high temperature finishing at atmospheric or higher pressure.
Patent NZ-534556-A (NZ)
Title: Cradle support for a fishing rod in use
Inventor: BARFIELD JAMES
IPC: A01K97/10
Filed: 2003-08-22
Abstract: A fishing rod angling support includes a pair of wire formed cradles 20, 40, one being taller than the other. The cradles may either be planted apart into the ground by pushing the pointed ends of the legs into the soil using the foot on the loop parts, or else connected together by the collapsible platform frame 60 for use on hard impenetrable surfaces.
Patent NZ-535763-A (NZ)
Title: (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
Inventor: ZENG QINGBEI
IPC: A61P11/00
Filed: 2003-04-16
Abstract: Disclosed is a 1-4 piperidinyl benzimidazole derivative represented by the structural formula (I) wherein the substituents are as described in the specification. Compounds of the type disclosed are histamine H3 receptor antagonists useful in the treatment of inflammatory diseases, allergic conditions and central nervous system disorders. Also disclosed is the use of a compound of formula (I) with and H1 receptor antagonist.
Patent NZ-537128-A (NZ)
Title: High mannose glucocerebrosidase preparations and methods of treating Gaucher disease
Inventor: KINOSHITA CAROL A
IPC: C12N9/99
Filed: 2001-08-17
Abstract: A purified high mannose glucocerebrosidase (hmGCB) preparation, wherein each hmGCB has four carbohydrate chains and at least three of the four carbohydrate chains in the hmGCB preparation have seven or more mannose residues of a precursor oligosaccharide. Also described is a pharmaceutical composition comprising the hmGCB preparation for treating Gaucher disease.
Patent NZ-542705-A (NZ)
Title: Light influencing element having raster elements coated with a reflective layer
Inventor: KELLER KATHARINA
IPC: F21V5/02
Filed: 2004-04-02
Abstract: A light influencing element for directing light into a predetermined range is disclosed. The element has a number of rib-like raster elements (7) arranged in a regular structure, where the side surfaces of the raster elements are coated with a reflecting layer (8) and the raster elements have a maximum height of 5mm.
Patent NZ-548508-A (NZ)
Title: Use of EPA and DHA in preventing cerebral damage wherein the dosage ranges from 0.5 to 5.0g of EPA and/or DHA daily
Inventor: CALDER PHILIP
IPC: A61P7/00
Filed: 2003-05-02
Abstract: Disclosed is the use of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or a mixture of EPA and DHA in the preparation of an oral medicament for preventing cerebral damage in patients who have symptoms of atherosclerosis of arteries supplying the brain. Further disclosed is the dosage of EPA and/or DHA daily will range from 0.5-5g. (62) Divided Out of 536507
Patent NZ-552452-A (NZ)
Title: A method for preparing an echinacea formulation from a combination of Echinacea angustifolia and Echinacea purpurea
Inventor: LEHMANN REG
IPC: A61K36/00
Filed: 2005-07-06
Abstract: Disclosed is a method for preparing an Echinacea formulation which includes a combination of Echinacea angustifolia and Echinacea purpurea, the method including the step of adding sufficient Echinacea angustifolia to the Echinacea purpurea such that the weight ratio of 2-ene alkylamide to 2,4-diene alkylamide in the formulation is between about 1:15 to about 2:1.
Patent NZ-553916-A (NZ)
Title: Toothbrush and methods of making and using same
Inventor: KAYSER STEVEN L
Filed: 2005-08-17
Abstract: The disclosed embodiments relate to a toothbrush and methods of making and using it, wherein an elongated body (12) up to 4.5 inches long, has a bristle brush head portion (14) and a handle portion (16). The body (12) is composed of a suitably flexible material so that an external force must be applied by the user in order to flex the elongated body (12) into a substantially rigid position for teeth brushing purposes.
Patent NZ-554398-A (NZ)
Title: Additive for feeds comprising Lactobacillus equi and at least one other Lactobacillus strain
Inventor: KADO YUKIKO
IPC: A23K20/195
Filed: 2004-10-13
Abstract: Disclosed is an additive for feeds comprising Lactobacillus equi cells and at least one bacterium selected from Lactobacillus salivarius, Lactobacillus reuteri, Lactobacillus crispatus and Lactobacillus johnsonii. Further disclosed is the additive for feeds as described further comprising an antibiotic.
Patent NZ-555117-A (NZ)
Title: Prevention of vertical endoparasite infections
Inventor: BACH THOMAS
IPC: A61P33/00
Filed: 2005-11-03
Abstract: The disclosure relates to the use of endoparasitic depsipeptides for the production of medicaments for prevention of vertical endoparasite infections which may be transmitted prenatally, i.e. from the mother to the child in the maternal body, or galactogenically via the milk.
Patent NZ-556649-A (NZ)
Title: Novel adenosine A3 receptor modulators
Inventor: BARALDI PIER
IPC: A01N43/54
Filed: 2006-02-01
Abstract: Disclosed is a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein X is CH or N and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the compound of formula (I) for the preparation of a medicament for the treatment of a condition that is mediated by the A3 receptor such as cancer, cerebral ischemia, inflammation, ischemic heart pre-conditioning and asthma.
Patent NZ-563166-A (NZ)
Title: Triazine-based affinity adsorbents for factor VIII and von willebrand's factor
Inventor: BETLEY JASON RICHARD
IPC: B01J20/286
Filed: 2006-05-09
Abstract: Disclosed is the use of a triazine based affinity adsorbent of formula II for the separation, removal, isolation, purification, characterisation, identification or quantification of Factor VIII, von Willebrand's Factor or a protein that is an analogue of either in vitro. The variables are as disclosed in the specification. Also disclosed are particular compounds of formula II as disclosed in the specification.
Patent NZ-567187-A (NZ)
Title: Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
Inventor: GUZI TIMOTHY J
IPC: A61K31/519
Filed: 2006-10-04
Abstract: The disclosure relates to a particular class of pyrazolo[1,5-a]pyrimidine compounds having the structure as shown herein, which are suitable as inhibitors of cyclin dependent kinases (CDK). The disclosure further relates to methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
Patent NZ-574946-A (NZ)
Title: A new antifungal composition comprising natamycin and phosphite
Inventor: STARK JACOBUS
IPC: A01N43/90
Filed: 2007-07-16
Abstract: Disclosed is an antifungal composition comprising phosphite such as potassium phosphite, sodium phosphite, ammonium phosphite, ethyl hydrogen phosphonate, fosetyl-aluminium complex, phosphorous acid or its alkali metal or alkaline earth metal salts, or a mixture thereof. and natamycin for the treatment of agricultural crops such as flower bulbs, tubers, root-tubers, rootstocks, onions and seed-potatoes.
Patent NZ-577613-A (NZ)
Title: Method for quantification of peptide and protein by lc/ms/ms
Inventor: MORITA YOSHIKAZU
IPC: G01N27/62
Filed: 2007-12-27
Abstract: Disclosed is a method which can quantify a specific protein or peptide contained in a trace amount with high accuracy and in a simple manner without the need of using any expensive reagent. A protein or peptide of interest can be quantified by LC/MS/MS by using, as an internal standard, a protein or peptide comprising an amino acid sequence having the reshuffling the binding order of amino acid residues in the amino acid sequence for the protein or peptide of interest.
Patent NZ-579804-A (NZ)
Title: Prompt nucleic acid delivery carrier composition
Inventor: TAKEUCHI HIROFUMI
IPC: A61K9/127
Filed: 2008-03-26
Abstract: Disclosed is a nucleic acid delivery carrier which can deliver a nucleic acid (e.g., siRNA) into a cell with high efficiency when the nucleic acid is administered to an animal-derived cell or an animal body, and which is less toxic and highly safe. Also disclosed is a nucleic acid delivery composition comprising the carrier and a nucleic acid. The nucleic acid delivery carrier comprises a combination of (A) diacylphosphatidyl choline, (B) at least one member selected from the group consisting of cholesterol and a derivative thereof, and (C) an aliphatic primary amine. A nucleic acid delivery composition can be prepared by mixing the nucleic acid delivery carrier with a nucleic acid.
Patent NZ-580599-A (NZ)
Title: An environmentally safe fire retardant protein free composition, a method of manufacturing thereof
Inventor: NILSSON MATS
IPC: C08K9/10
Filed: 2009-10-21
Abstract: Disclosed is a method for producing an all-purpose harmless fire retardant protein free composition that is adaptable to be incorporated into a range of differing material, of which said material forms an intermediate or finished product requiring fire retardant characteristics, said method including the steps of; (A) adding to a sodium hydroxide solution to form a solution with a Ph in the range of 1.0 to 3.0, the acid being selected from the group consisting of mono-carboxylic acid, anhydrous di-carboxylic acid and anhydrous tri-carboxylic acid and mixtures thereof, the mono-carboxylic acid being select from formic acid, acetic acid, stearic acid, benzoic acid and mixtures thereof the anhydrous di-carboxylic acid being selected from the group consisting of oxalic acid, malonic acid, succinic acid, gìutaric acid, and mixtures thereof, and the anhydrous tri-carboxylic acid consisting of citric acid, (B) adding alkali pyrophosphate and water to A for an endothermic process, (C) adding calcium carbonates to the acidic solution B for the generation of an exothermic reaction, (D) once composition C becomes clumpy, pouring composition C out onto a drying bed for drying, (E) once the composition of step D is dried, subjecting the composition of step D to one or more of grounding, milling and grinding to achieve particles of less than 0.020mm, (F). encapsulating the particles of step E with a surface coating material, the surface coating material being selected from the group consisting of polysaccharide, tristearate, a wax of a polyethylene based material and mixtures thereof, wherein the encapsulation of step F provides means for the particles to remain inactive within the intermediate or finished product until the intermediate or finished product is ignited by fire.
Patent NZ-583456-A (NZ)
Title: Use of niacin based anhydrous compositions suitable for enhancing sexual wellness
IPC: A61K31/455
Filed: 2008-08-20
Abstract: Disclosed is the use, in the preparation of a medicament for use in a method of attaining enhanced sexual wellness of an individual by administering the medicament to the genital areas of said individual, of an anhydrous composition comprising from about 0.1 to about 0.5% by weight of a niacin derivative selected from the group consisting of niacin, nicotinic acid, methyl niconate, methyl nicotinate, benzyl nicotinate, nicotinamide and niacinamide and an acceptable carrier consisting essentially of one or more polyhydric alcohols, wherein said niacin derivative is dissolved in said carrier and is present in an amount effective to increase the blood flow to human tissue when said composition is applied to said human tissue and wherein said composition is non-flushing and said increase in blood flow is less than a 300% increase. Said composition is capable of penetrating the epidermis of said human tissue when applied to said human tissue, and preferably, it should be administered between 5 minutes to 30 minutes prior to intercourse.
Patent NZ-588423-A (NZ)
Title: Pneumatic drifter with replaceable foot pieces which have shear load carrying mating features
Inventor: MURRAY WILLIAM JAMES
IPC: E21B3/02
Filed: 2008-12-19
Abstract: 588423 A rock drill, with a cylinder body including a central channel adapted to be connected in line to a percussive drill bit, the cylindrical body has a bottom side with a foot pad. The foot pad has a plurality of ridges. The rock drill also has a sliding frame and a support member. The support member is removably connected to the cylinder body. The support member has a mating surface. The mating surface includes a plurality of corresponding ridges adapted to mate with the plurality of ridges of the foot pad which allow the transfer of shear forces. The support member is configured to guide the movement of the cylinder body relative to the sliding frame by contacting the sliding frame.
Patent NZ-593118-A (NZ)
Title: METHODS OF ENHANCING THE RESISTANCE OF PLANTS TO BACTERIAL PATHOGENS BY TRANSFORMING PLANTS WITH A POLYNUCLEOTIDE CONSTRUCT COMPRISING A PROMOTER AND A NUCLEOTIDE SEQUENCE THAT ENCODES AN EF-Tu RECEPTOR
Inventor: ZIPFEL CYRIL B
IPC: A01H7/00
Filed: 2009-11-03
Abstract: 593118 Disclosed is a method for enhancing the resistance of a plant to at least one eubacterial pathogen, said method comprising the steps of: Transforming a plant cell with a polynucleotide construct comprising a promoter and a nucleotide sequence that encodes an EF-Tu receptor (EFR), wherein said promoter is operably linked to said nucleotide sequence and said promoter is capable of driving expression of said nucleotide sequence in a plant cell; and Regenerating a transformed plant from said transformed plant cell; wherein said transformed plant has enhanced resistance to at least one eubacterial pathogen. Further disclosed is a plant comprising a stably incorporated in it genome a polynucleotide construct comprising a promoter and a nucleotide sequence that encodes an EFR, wherein said promoter is operable linked to said nucleotide sequence and said promoter is capable of driving expression of said nucleotide sequence in a plant cell, wherein said transformed plant has enhanced resistance to at least one bacterial pathogen when compared to a wild-type plant.
Patent NZ-593526-A (NZ)
Title: Determination of apnea/hypopnea during CPAP treatment through calculating an average respiratory airflow over a comparative short and long term interval
Inventor: ALDER MATTHEW
IPC: A61M16/00
Filed: 2007-03-06
Abstract: An apparatus for detecting the occurrence of apnea and/or hypopnea events in a patient, and corresponding method is disclosed. The apparatus includes a sensor for sensing respiratory flow, first and second filters to iteratively calculate a first and second average respiratory airflow over a first and second time interval; the second time interval being shorter than the first time interval. The apparatus also includes a controller in communication with the sensor and the first and second filters. The controller is programmed to iteratively calculate a predetermined fraction of the first average respiratory airflow and compare this value with the second average respiratory airflow such that the comparison can determine an apnea or hypopnea event. The controller then continues to calculate the second average respiratory airflow and compare this value to the predetermined fraction of the first average respiratory airflow to confirm the occurrence of the apnea or hypopnea event. Upon determining the apnea or a hypopnea event, the calculation of the first average respiratory airflow is stopped until the apnea or the hypopnea ends.
Patent NZ-595594-A (NZ)
Title: Improvements in & relating to the comminution of waste & other materials
Inventor: SHARP RODNEY WARWICK
IPC: B02C4/02
Filed: 2010-03-07
Abstract: Comminution apparatus 1 comprising an outer comminution drum 2 and at least one inner comminution drum 3, where the outer comminution drum 2 has a hollow portion and a longitudinal axis 6, and the inner comminution drum 3 has a longitudinal axis 5 and is positioned to be present within the hollow portion of the outer comminution drum 2. The longitudinal axes of both drums are substantially parallel to each other, but not coaxial. At least one of the outer comminution drum 2, and an inner comminution drum 3 is rotatable about its longitudinal axis. The inner comminution drum 3 has at least one projecting macerating feature on its outer surface, and the outer comminution drum 2 has at least one projecting macerating feature on its inner surface. During rotation of at least one of the outer comminution drum 2 and the inner comminution drum 3, about its longitudinal axis the projecting macerating features come into close proximity, but do not make contact with each other.